Thrombin and protease-activated receptor 1(PAR1) signaling has been shown to promote tumor growth, metastasis, and immune evasion in murine pancreatic adenocarcinoma (PDAC) models (147). This evidence concerns the gene F2R and pancreatic adenocarcinoma.